TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
LXEO

Lexeo Therapeutics, Inc.

Healthcare · Biotechnology · —

3.50$ -13.5% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow LXEO
Line item 2020 2021 2022 2023 2024 2025
-0.12 -1.76 -2.17 -2.23 -2.55 -1.84
0.00 0.00 0.05 0.07 0.06 0.01
0.00 0.02 0.07 0.11 0.39 0.23
0.01 0.24 0.07 0.06 0.09 -0.18
0.00 0.01 0.04 0.01 0.02 0.01
– -0.01 -0.04 -0.01 -2.96 -1.68
– – – 0.00 0.00 1.49
– 0.00 -0.01 0.13 -0.01 -0.01
1.29 5.99 0.01 3.90 2.79 4.04
1.16 4.23 -2.20 1.66 -2.72 0.52
-0.12 -1.76 -2.20 -2.24 -2.57 -1.84

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?